Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-Jun-24 7:13 PM View:  | AcelRx Pharmaceuticals, Inc. (TLPH) | 24-Jun-24 | Grant | 2,174 | -- | -- | 90% 2.42K to 4.59K | |
| 13-Dec-23 4:35 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Oct-23 | Grant | 581 | -- | -- | 32% 1.84K to 2.42K | |
| 15-Jul-22 7:29 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 15-Jul-22 | Grant | 15,500 | -- | -- | 73% 21.25K to 36.75K | |
| 29-Dec-21 4:20 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 28-Dec-21 | Disposition (change in control) | 16,157 | $38.25 | $618,005.00 | (100%) 16.16K to 0 | < 1% |
| 17-Jun-21 5:25 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 17-Jun-21 | Grant | 10,000 | -- | -- | 89% 11.25K to 21.25K | |
| 07-Jun-21 9:36 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 03-Jun-21 | Option Exercise | 3,333 | -- | -- | 13% 25.74K to 29.07K | |
| 16-Feb-21 10:00 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 10-Dec-20 | Acquisition (other) | 10,137 | -- | -- | 65% 15.6K to 25.74K | |
| 16-Feb-21 10:00 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 26-Aug-20 | Acquisition (other) | 15,601 | -- | -- | 100% 0 to 15.6K | |
| 16-Jun-20 7:15 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 16-Jun-20 | Grant | 7,500 | -- | -- | 200% 3.75K to 11.25K | |
| 25-Jun-19 7:03 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 25-Jun-19 | Grant | 3,750 | -- | -- | 100% 0 to 3.75K | |
| 14-Nov-18 4:25 PM View: | Aadi Bioscience, Inc. (ARPO) | 12-Nov-18 | Purchase | 30,000 | $2.01 | $60,300.00 | 1525% 1.97K to 31.97K | |
| 14-Nov-18 4:25 PM View: | Aadi Bioscience, Inc. (ARPO) | 09-Nov-18 | Purchase | 1,967 | $1.95 | $3,835.65 | 100% 0 to 1.97K | |
| 17-Mar-15 4:41 PM View: | Genocea Biosciences, Inc. (GNCA) | 17-Mar-15 | Private Purchase | 700,000 | $8.25 | $5,775,000.00 | 54% 1.29M to 1.99M | |
| 11-Mar-14 8:33 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 07-Mar-14 | Disposition (other) Duplicate | 1,300,000 | -- | -- | (31%) 4.17M to 2.87M | |
| 11-Feb-14 9:49 PM View: | Genocea Biosciences, Inc. (GNCA) | 10-Feb-14 | Conversion | 1,041,480 | -- | -- | 100% 0 to 1.04M | |
| 11-Feb-14 9:49 PM View: | Genocea Biosciences, Inc. (GNCA) | 10-Feb-14 | Purchase | 250,931 | $12.00 | $3,011,170.00 | 24% 1.04M to 1.29M | |
| 05-Feb-14 6:21 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 04-Feb-14 | Conversion | 1,534,750 | -- | -- | 100% 0 to 1.53M | |
| 05-Feb-14 6:21 PM View: | Dicerna Pharmaceuticals Inc (DRNA) | 04-Feb-14 | Purchase | 200,000 | $15.00 | $3,000,000.00 | 13% 1.53M to 1.73M | |
| 05-Sep-12 4:50 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Sep-12 | Disposition (change in control) | 92,000 | $1.82 | $167,440.00 | (16%) 565.67K to 473.67K | (< 1%) |
| 05-Sep-12 4:50 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Sep-12 | Disposition (change in control) | 473,671 | $1.82 | $862,081.00 | (100%) 473.67K to 0 | (< 1%) |
| 15-Dec-11 4:29 PM View: | Allos Therapeutics, Inc. (ALTH) | 13-Dec-11 | Grant | 90,000 | -- | -- | 36% 250.0K to 340.0K | |
| 11-Jan-10 7:32 PM View: | Allos Therapeutics, Inc. (ALTH) | 11-Jan-10 | Option Exercise | 45,428 | $2.42 | $109,908.00 | 10% 475.67K to 521.1K | |
| 11-Jan-10 7:32 PM View: | Allos Therapeutics, Inc. (ALTH) | 11-Jan-10 | Market Option Sale (Planned) | 45,428 | $7.30 | $331,738.00 | (9%) 521.1K to 475.67K | < 1% |
| 11-Jan-10 7:32 PM View: | Allos Therapeutics, Inc. (ALTH) | 08-Jan-10 | Option Exercise | 45,429 | $2.42 | $109,911.00 | 10% 475.67K to 521.1K | |
| 11-Jan-10 7:32 PM View: | Allos Therapeutics, Inc. (ALTH) | 08-Jan-10 | Market Option Sale (Planned) | 45,429 | $7.11 | $322,918.00 | (9%) 521.1K to 475.67K | (3%) |
| 11-Jan-10 7:32 PM View: | Allos Therapeutics, Inc. (ALTH) | 07-Jan-10 | Option Exercise | 45,429 | $2.42 | $109,911.00 | 10% 475.67K to 521.1K | |
| 11-Jan-10 7:32 PM View: | Allos Therapeutics, Inc. (ALTH) | 07-Jan-10 | Market Option Sale (Planned) | 45,429 | $6.76 | $307,114.00 | (9%) 521.1K to 475.67K | (8%) |
| 06-Jan-10 6:03 PM View: | Allos Therapeutics, Inc. (ALTH) | 06-Jan-10 | Option Exercise | 45,429 | $2.42 | $109,911.00 | 10% 475.67K to 521.1K | |
| 06-Jan-10 6:03 PM View: | Allos Therapeutics, Inc. (ALTH) | 06-Jan-10 | Market Option Sale (Planned) | 45,429 | $6.78 | $308,163.00 | (9%) 521.1K to 475.67K | < 1% |
| 06-Jan-10 6:03 PM View: | Allos Therapeutics, Inc. (ALTH) | 05-Jan-10 | Option Exercise | 45,428 | $2.42 | $109,908.00 | 10% 475.67K to 521.1K | |
| 06-Jan-10 6:03 PM View: | Allos Therapeutics, Inc. (ALTH) | 05-Jan-10 | Market Option Sale (Planned) | 45,428 | $6.64 | $301,497.00 | (9%) 521.1K to 475.67K | (2%) |
| 06-Jan-10 6:03 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Jan-10 | Option Exercise | 25,428 | $2.42 | $61,520.50 | 5% 475.67K to 501.1K | |
| 06-Jan-10 6:03 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Jan-10 | Market Option Sale (Planned) | 25,428 | $6.54 | $166,220.00 | (5%) 501.1K to 475.67K | (3%) |
| 16-Feb-10 5:34 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Dec-09 | Gift | 224,871 | -- | -- | 47% 475.67K to 700.54K | |
| 16-Feb-10 5:34 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Dec-09 | Gift | 224,871 | -- | -- | (32%) 700.54K to 475.67K | |
| 06-Feb-09 5:20 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Feb-09 | Option Exercise | 36,400 | $2.42 | $88,066.20 | 8% 475.67K to 512.07K | 237% |
| 06-Feb-09 5:20 PM View: | Allos Therapeutics, Inc. (ALTH) | 04-Feb-09 | Market Option Sale (Planned) | 36,400 | $9.03 | $328,692.00 | (7%) 512.07K to 475.67K | 14% |
| 03-Sep-08 5:00 PM View: | Allos Therapeutics, Inc. (ALTH) | 02-Sep-08 | Option Exercise | 40,000 | $2.42 | $96,776.00 | 8% 475.67K to 515.67K | 296% |
| 03-Sep-08 5:00 PM View: | Allos Therapeutics, Inc. (ALTH) | 02-Sep-08 | Market Option Sale (Planned) | 40,000 | $9.68 | $387,200.00 | (8%) 515.67K to 475.67K | 19% |
| 31-May-07 3:36 PM View: | Sirtris Pharmaceuticals, Inc. (SIRT) | 29-May-07 | Conversion | 1,846,140 | -- | -- | 100% 0 to 1.85M | |
| 26-May-05 1:15 PM View: | Allos Therapeutics, Inc. (ALTH) | 25-May-05 | Option Exercise | 248,000 | $0.52 | $129,995.00 | 109% 227.67K to 475.67K | |
| 23-Mar-04 10:00 PM View: | Allos Therapeutics, Inc. (ALTH) | 23-Mar-04 | Grant | 400 | $18.00 | $7,200.00 | < 1% 227.27K to 227.67K |